Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins

Infection and Immunity

Volumn 76, Issue 10, 2008, Pages 4624-4632

  Upritchard, Hamish G ^a   Cordwell, Stuart J ^b,c   Lamont, Iain L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Australian Proteome Analysis Facility   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZURIN; BACTERIAL PROTEIN; ELASTASE; ETHYLENEDIAMINE; IRON CHELATING AGENT; PASP PROTEIN; PROTEIN; PRPL PROTEIN; PSEUDOMONAS AERUGINOSA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CYSTIC FIBROSIS; CYTOLYSIS; GRAM NEGATIVE INFECTION; IMMUNE RESPONSE; IMMUNOPROTEOMICS; MOLECULAR RECOGNITION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; STRUCTURAL HOMOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; PSEUDOMONAS AERUGINOSA;

EID: 53649111911     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01707-07     Document Type: Article

References (58)

1. Anderson, T. R., T. C. Montie, M. D. Murphy, and V. P. McCarthy. 1989. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis. J. Clin. Microbiol. 27:2789-2793.
2. Arevalo-Ferro, C., J. Buschmann, G. Reil, A. Gorg, L. Wiehlmann, B. Tummler, L. Eberl, and K. Riedel. 2004. Proteome analysis of intraclonal diversity of two Pseudomonas aeruginosa TB clone isolates. Proteomics 4:1241-1246.
3. Arevalo-Ferro, C., M. Hentzer, G. Reil, A. Gorg, S. Kjelleberg, M. Givskov, K. Riedel, and L. Eberl. 2003. Identification of quorum-sensing regulated proteins in the opportunistic pathogen Pseudomonas aeruginosa by proteomics. Environ. Microbiol. 5:1350-1369.
4. Bauman, S. J., and M. J. Kuehn. 2006. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 8:2400-2408.
5. Beckmann, C., M. Brittnacher, R. Ernst, N. Mayer-Hamblett, S. I. Miller, and J. L. Burns. 2005. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 73:444-452.
6. Bragonzi, A., D. Worlitzsch, G. B. Pier, P. Timpert, M. Ulrich, M. Hentzer, J. B. Andersen, M. Givskov, M. Conese, and G. Doring. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419.
7. Brett, M. M., A. T. Ghoneim, and J. M. Littlewood. 1988. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J. Clin. Microbiol. 26:1565-1570.
8. Brett, M. M., A. T. Ghoneim, and J. M. Littlewood. 1987. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch. Dis. Child. 62:357-361.
9. Bullen, J. J., H. J. Rogers, and E. Griffiths. 1978. Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80:1-35.
10. Burns, J. L., R. L. Gibson, S. McNamara, D. Yim, J. Emerson, M. Rosenfeld, P. Hiatt, K. McCoy, R. Castile, A. L. Smith, and B. W. Ramsey. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183:444-452.
11. Cahan, R., I. Axelrad, M. Safrin, D. E. Ohman, and E. Kessler. 2001. A secreted aminopeptidase of Pseudomonas aeruginosa. Identification, primary structure, and relationship to other aminopeptidases. J. Biol. Chem. 276: 43645-43652.
12. Chmiel, J. F., and P. B. Davis. 2003. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir. Res. 4:8.
13. Diggle, S. P., S. Matthijs, V. J. Wright, M. P. Fletcher, S. R. Chhabra, I. L. Lamont, X. Kong, R. C. Hider, P. Cornelis, M. Camara, and P. Williams. 2007. The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem. Biol. 14:87-96.
14. Driscoll, J. A., S. L. Brody, and M. H. Kollef. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368.
15. Ernst, R. K., D. A. D'Argenio, J. K. Ichikawa, M. G. Bangera, S. Selgrade, J. L. Burns, P. Hiatt, K. McCoy, M. Brittnacher, A. Kas, D. H. Spencer, M. V. Olson, B. W. Ramsey, S. Lory, and S. I. Miller. 2003. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ. Microbiol. 5:1341-1349.
16. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951.
17. Haas, G., G. Karaali, K. Ebermayer, W. G. Metzger, S. Lamer, U. Zimny-Arndt, S. Diescher, U. B. Goebel, K. Vogt, A. B. Roznowski, B. J. Wiedenmann, T. F. Meyer, T. Aebischer, and P. R. Jungblut. 2002. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2:313-324.
18. Handfield, M., D. E. Lehoux, F. Sanschagrin, M. J. Mahan, D. E. Woods, and R. C. Levesque. 2000. In vivo-induced genes in Pseudomonas aeruginosa. Infect. Immun. 68:2359-2362.
19. Harlow, E., and D. Lane. 1999. Using antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Hirose, I., K. Sano, I. Shioda, M. Kumano, K. Nakamura, and K. Yamane. 2000. Proteome analysis of Bacillus subtilis extracellular proteins: a twodimensional protein electrophoretic study. Microbiology 146:65-75.
21. Hollsing, A. E., M. Granstrom, M. L. Vasil, B. Wretlind, and B. Strandvik. 1987. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J. Clin. Microbiol. 25:1868-1874.
22. Hoshino, T., K. Kose-Terai, and K. Sato. 1992. Solubilization and reconstitution of the Pseudomonas aeruginosa high affinity branched-chain amino acid transport system. J. Biol. Chem. 267:21313-21318.
23. Hunt, T. A., W. T. Peng, I. Loubens, and D. G. Storey. 2002. The Pseudomonas aeruginosa alternative sigma factor PvdS controls exotoxin A expression and is expressed in lung infections associated with cystic fibrosis. Microbiology 148:3183-3193.
24. Kappler, M., A. Kraxner, D. Reinhardt, B. Ganster, M. Griese, and T. Lang. 2006. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax 61:684-688.
25. Kurien, B. T., and R. H. Scofield. 2003. Protein blotting: a review. J. Immunol. Methods 274:1-15.
26. Lewenza, S., J. L. Gardy, F. S. Brinkman, and R. E. Hancock. 2005. Genome-wide identification of Pseudomonas aeruginosa exported proteins using a consensus computational strategy combined with a laboratory-based PhoA fusion screen. Genome Res. 15:321-329.
27. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051-1060.
28. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
29. Marquart, M. E., A. R. Caballero, M. Chomnawang, B. A. Thibodeaux, S. S. Twining, and R. J. O'Callaghan. 2005. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Investig. Ophthalmol. Vis. Sci. 46:3761-3768.
30. Meyer, J.-M., A. Stintzi, D. D. Vos, P. Cornelis, R. Tappe, K. Taraz, and H. Budzikiewicz. 1997. Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143:35-43.
31. Neuhoff, V., N. Arold, D. Taube, and W. Ehrhardt. 1988. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9:255-262.
32. Nouwens, A. S., S. A. Beatson, C. B. Whitchurch, B. J. Walsh, H. P. Schweizer, J. S. Mattick, and S. J. Cordwell. 2003. Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology 149:1311-1322.
33. Nouwens, A. S., M. D. Willcox, B. J. Walsh, and S. J. Cordwell. 2002. Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa. Proteomics 2:1325-1346.
34. Ochsner, U. A., Z. Johnson, I. L. Lamont, H. E. Cunliffe, and M. L. Vasil. 1996. Exotoxin A production in Pseudomonas aeruginosa requires the iron-regulated pvdS gene encoding an alternative sigma factor. Mol. Microbiol. 21:1019-1028.
35. Palmer, K. L., L. M. Mashburn, P. K. Singh, and M. Whiteley. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277.
36. Pressler, T., B. Frederiksen, M. Skov, P. Garred, C. Koch, and N. Hoiby. 2006. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection - a case control study. J. Cyst. Fibros. 5:9-15.
37. Pressler, T., S. S. Pedersen, F. Espersen, N. Hoiby, and C. Koch. 1990. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic P. aeruginosa infection investigated by ELISA. Clin. Exp. Immunol. 81:428-434.
38. Ramsey, D. M., and D. J. Wozniak. 2005. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol. Microbiol. 56:309-322.
39. Sambrook, J., D. W. Russell, and N. Irwin. 2000. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
40. Schuster, M., C. P. Lostroh, T. Ogi, and E. P. Greenberg. 2003. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 185:2066-2079.
41. Singh, P. K., A. L. Schaefer, M. R. Parsek, T. O. Moninger, M. J. Welsh, and E. P. Greenberg. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764.
42. Smith, R. S., and B. H. Iglewski. 2003. Pseudomonas aeruginosa quorum-sensing systems and virulence. Curr. Opin. Microbiol. 6:56-60.
43. Spencer, D. H., A. Kas, E. E. Smith, C. K. Raymond, E. H. Sims, M. Hastings, J. L. Burns, R. Kaul, and M. V. Olson. 2003. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185:1316-1325.
44. Sriramulu, D. D., M. Nimtz, and U. Romling. 2005. Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment. Proteomics 5:3712-3721.
45. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. L. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K.-S. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. W. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959-964.
46. Ulanova, M., T. D. Petersen, O. Ciofu, P. Jensen, M. Hahn-Zoric, L. A. Hanson, and N. Hoiby. 1997. The clonal antibody response to Pseudomonas aeruginosa heat shock protein is highly diverse in cystic fibrosis patients. APMIS 105:449-456.
47. Vasil, M. L. 2007. How we learnt about iron acquisition in Pseudomonas aeruginosa: a series of very fortunate events. Biometals 20:587-601.
48. Vasil, M. L., and U. A. Ochsner. 1999. The response of Pseudomonas aeruginosa to iron: genetics, biochemistry and virulence. Mol. Microbiol. 34:399-413.
49. Wagner, V. E., D. Bushnell, L. Passador, A. I. Brooks, and B. H. Iglewski. 2003. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 185:2080-2095.
50. Wagner, V. E., J. G. Frelinger, R. K. Barth, and B. H. Iglewski. 2006. Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals. Trends Microbiol. 14:55-58.
51. Walduck, A., T. Rudel, and T. F. Meyer. 2004. Proteomic and gene profiling approaches to study host responses to bacterial infection. Curr. Opin. Microbiol. 7:33-38.
52. Wang, J., S. Lory, R. Ramphal, and S. Jin. 1996. Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22:1005-1012.
53. Wehmhoner, D., S. Haussler, B. Tummler, L. Jansch, F. Bredenbruch, J. Wehland, and I. Steinmetz. 2003. Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J. Bacteriol. 185:5807-5814.
54. West, S. E., L. Zeng, B. L. Lee, M. R. Kosorok, A. Laxova, M. J. Rock, M. J. Splaingard, and P. M. Farrell. 2002. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 287:2958-2967.
55. Wilderman, P. J., A. I. Vasil, Z. Johnson, M. J. Wilson, H. E. Cunliffe, I. L. Lamont, and M. I. Vasil. 2001. Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene Pseudomonas aeruginosa. Infect. Immun. 69:5385-5394.
56. Wolfgang, M. C., B. R. Kulasekara, X. Liang, D. Boyd, K. Wu, Q. Yang, C. G. Miyada, and S. Lory. 2003. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 100:8484-8489.
57. Worlitzsch, D., R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, and G. Doring. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Investig. 109:317-325.
58. Zaborina, O., N. Dhiman, M. Ling Chen, J. Kostal, I. A. Holder, and A. M. Chakrabarty. 2000. Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology 146:2521-2530.